ArticleFrontiers in immunology2024

The complement regulatory protein CD46 serves as a novel biomarker for cervical cancer diagnosis and prognosis evaluation.

Jun-Hui Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.